Education and research experience
9/2020 – today: Associate professor in Pharmacology, Dept of Food and Drug, University of Parma, Italy
7/2001 – 9/2020: Assistant professor in Pharmacology, Dept of Food and Drug, University of Parma, Italy.
1/1996 – 12/2000: Ph.D. in “Gastroenterological pharmacology”, University of Parma
4/1999 – 10/1999; 11/2000 – 1/2021: Visiting scientist - Dept. of Anatomy and Developmental Biology, University College London, London (UK) – Supervisor: Prof. G. Gabella
11/1989 – 11/1995: Degree in Medicinal Chemistry and Pharmaceutical Technology (110/110 cum laude)
Financed national and international projects
1/2021 - 12/2024: ESR supervisor in the programme H2020-MSCA-ITN-2020, Grant agreement n. 956851 “Boosting advanced doctoral training in innovative colon targeting drug (COLOTAN)” with a project entitled “Enteroids and cytokines: an in vitro model of drug absorption in the inflamed gut”
10/2019-2021: Principal investigator, “CCR6 blockade as novel therapeutic strategy against Inflammatory Bowel Disease”, grant awarded by European Crohn’s and Colitis Organization
2015 – 2018: Co-investigator, Optimization of Eph receptor ligands as molecularly targeted chemotherapeutic drugs” financed by Associazione Italiana per le Ricerca contro il Cancro (AIRC).
10/2011 - 10/2013: Co-investigator, “Study of the mechanisms responsible for dysmotility of the upper digestive tract in the experimental Parkinson’s disease”
9/2008 – 10/2010: Co-investigator, “Pharmacological modulation of the serotonergic system in mesenteric ischemia”
11/2004 – 12/2006: Co-investigator, “Contribution of the serotoninergic system to the functional and inflammatory injuries induced by mesenteric ischemia-reperfusion”
11/2003 – 12/2005: Co-investigator, “Role played by adenosine in experimental mesenteric ischemia-reperfusion injury”
12/2002 – 1/2005: Co-investigator, “Local and remote functional alterations in the inflammatory process activated by mesenteric ischemia-reperfusion”
Research interests
Prof. Bertoni has participated to several projects focussed primarily on the study of the altered functions of the gastrointestinal tract in patho-physiological conditions through the application of binding, biochemical and functional in vitro and in vivo studies. She is currently interested in the development of human intestinal organoids as translational cell-based model of human gut epithelium in healthy and inflammatory conditions.
Her scientific activity is documented by 77 indexed articles on international journals and 88 communications to national and international meetings.
